Development of a recombinant FimCH vaccine for urinary tract infections.
Langermann
Solomon
S
MedImmune, Inc., Gaithersburg, MD, USA.
Ballou
W Ripley
WR
D018830:Adhesins, Escherichia coli / Q000235:genetics / Q000276:immunology*; D004926:Escherichia coli / Q000276:immunology; D036781:Fimbriae Proteins / Q000235:genetics / Q000276:immunology*; D010861:Fimbriae, Bacterial / Q000276:immunology; D006801:Humans; D014552:Urinary Tract Infections / Q000276:immunology* / Q000628:therapy; D014614:Vaccines, Synthetic / Q000627:therapeutic use*
D018830:Adhesins, Escherichia coli; D014614:Vaccines, Synthetic; C058769:fimH protein, E coli; D036781:Fimbriae Proteins